Anaptysbio (ANAB) Income from Continuing Operations: 2015-2024
Historic Income from Continuing Operations for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$145.2 million.
- Anaptysbio's Income from Continuing Operations rose 146.00% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 48.91%. This contributed to the annual value of -$145.2 million for FY2024, which is 11.24% up from last year.
- Latest data reveals that Anaptysbio reported Income from Continuing Operations of -$145.2 million as of FY2024, which was up 11.24% from -$163.6 million recorded in FY2023.
- In the past 5 years, Anaptysbio's Income from Continuing Operations registered a high of -$19.9 million during FY2020, and its lowest value of -$163.6 million during FY2023.
- For the 3-year period, Anaptysbio's Income from Continuing Operations averaged around -$145.9 million, with its median value being -$145.2 million (2024).
- Per our database at Business Quant, Anaptysbio's Income from Continuing Operations skyrocketed by 79.52% in 2020 and then crashed by 189.98% in 2021.
- Anaptysbio's Income from Continuing Operations (Yearly) stood at -$19.9 million in 2020, then plummeted by 189.98% to -$57.8 million in 2021, then crashed by 122.72% to -$128.7 million in 2022, then declined by 27.11% to -$163.6 million in 2023, then rose by 11.24% to -$145.2 million in 2024.